J&J | JNJ - Des Atouts





Des Atouts Changement Date
AbbVie USD 135.12B 1.35B 2026-06
Abbott USD 110.43B 23.72B 2026-03
Amgen USD 95.64B 3.14B 2026-06
AstraZeneca USD 115.83B 1.82B 2026-06
Baxter International USD 19.79B 55M 2026-06
Bayer EUR 107.29B 659M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Biogen USD 32.09B 2.6B 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
CONMED USD 2.3B 14.64M 2026-06
Cooper Companies USD 12.67B 191.1M 2026-06
Dexcom USD 6.46B 178M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 201.06B 167M 2026-06
Medtronic USD 93.31B 278M 2026-06
Merck USD 129.8B 1.12B 2026-06
Merit Medical Systems USD 2.86B 144.34M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teva Pharmaceutical Industries USD 39.86B 183M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06
Zoetis USD 15.08B 77M 2026-06